Liquid-based Cytology Test Use by Office-based Physicians: United States, 2006–2007

In the United States, liquid-based cytology (LBC) has rapidly become a common method used in cervical cancer screening (1–4). Its popularity with both medical professionals and insurance companies may be related to the ease of microscopic interpretation and the potential for performing additional medical tests on the same sample (2,5,6). This popularity may also be attributable to direct marketing to physicians, to patients, and to laboratories (1). However, limited information is available...